Spectral AI Showcases DeepView System at 2026 American Burn Association Meeting

Event summary

  • Spectral AI will feature its DeepView® System at the 2026 American Burn Association Annual Meeting in Orlando, Florida, from April 14-17.
  • The DeepView System combines multispectral imaging with AI to assess burn wound healing potential, with a De Novo 510(k) application submitted to the FDA in June 2025.
  • Spectral AI will present real-world experience with the DeepView System at the ABA Innovation Theater on April 14, hosted by Consultant Plastic & Reconstructive Surgeon Christopher J. Lewis.
  • The event brings together over 2,200 clinicians, researchers, and burn care leaders.

The big picture

Spectral AI's participation in the American Burn Association meeting underscores the growing role of AI in burn care diagnostics. The event provides a platform to validate the DeepView System's real-world efficacy, which is critical as the company seeks FDA clearance. Success here could accelerate adoption in a sector increasingly focused on data-driven treatment decisions.

What we're watching

Regulatory Approval
The pace at which the FDA reviews Spectral AI's De Novo 510(k) application for the DeepView System will determine its commercial availability.
Market Adoption
Whether Spectral AI can secure partnerships with major burn care institutions following the conference.
Competitive Positioning
How Spectral AI differentiates its AI-driven diagnostics in a crowded medical device market.